Department of Clinical Medicine

You are here: » Henrik Hasle » Activities

Henrik Hasle

1 - 75 out of 75Page size: 100
RSS feed of this list
Sort by: Start date
  1. 2022

  2. Erythrocyte deformability and the spleen in children with sickle cell anaemia

    Henrik Hasle (Lecturer)

    29 Apr 2022

    Activity: Other activity types › Other

  3. 2020

  4. Department of Clinical Medicine - Department of Paediatrics (Organisational unit)

    Henrik Hasle (Member)

    13 Nov 2020

    Activity: Membership types › Member of review committee

  5. 2019

  6. I-BFM-AML-SG biannual meeting

    Henrik Hasle (Organizer)

    7 Dec 2019

    Activity: Participating in or organising an event types › Participation in or organisation of workshop, seminar or course

  7. Unique pattern of leukemia in Down syndrome. Disparities and Outcomes in Acute Leukemia.

    Henrik Hasle (Lecturer)

    4 Nov 2019

    Activity: Talk or presentation types › Lecture and oral contribution

  8. Bedømmelse af PhD afhandling. (Event)

    Henrik Hasle (Member)

    18 Sept 2019

    Activity: Membership types › Member of review committee

  9. Bedømmelse af PhD afhandling. (Event)

    Henrik Hasle (Member)

    3 Jul 2019

    Activity: Membership types › Member of review committee

  10. I-BFM-AML-SG biannual meeting

    Henrik Hasle (Organizer)

    20 May 2019

    Activity: Participating in or organising an event types › Participation in or organisation of workshop, seminar or course

  11. Overview of childhood AML. Paediatric Strategy Forum for Medicinal Product Development for AML in Children and Adolescents

    Henrik Hasle (Lecturer)

    11 Apr 2019

    Activity: Talk or presentation types › Lecture and oral contribution

  12. Diagnostics and classification of patients with MDS and myeloproliferative disorders

    Henrik Hasle (Lecturer)

    6 Apr 2019

    Activity: Talk or presentation types › Lecture and oral contribution

  13. Individualized treatment for patients with JMML

    Henrik Hasle (Lecturer)

    5 Apr 2019

    Activity: Talk or presentation types › Lecture and oral contribution

  14. 2016

  15. Central nervous system involvement in childhood acute lymphoblastic leukemia

    Henrik Hasle (Participant)

    13 Dec 2016

    Activity: Other activity types › Other

  16. Treatment compliance and toxicity in children with Down syndrome and acute lymphoblastic leukaemia.

    Henrik Hasle (Participant)

    1 Nov 2016

    Activity: Other activity types › Other

  17. I-BFM SG The International BFM Study Group (External organisation)

    Henrik Hasle (Chairman)

    2016 → …

    Activity: Membership types › Member of committee, council, board

  18. 2015

  19. Aarhus University (External organisation)

    Henrik Hasle (Member)

    30 Oct 2015

    Activity: Membership types › Member of review committee

  20. Aarhus University (External organisation)

    Henrik Hasle (Member)

    22 Jun 2015

    Activity: Membership types › Member of review committee

  21. 2013

  22. Mental late effect in childhood cancer survivors and their siblings.

    Henrik Hasle (Participant)

    1 Nov 2013

    Activity: Other activity types › Other

  23. Quantification of DNA-thioguanine in children with acute lymphoblastic leukemia -: A potential dose-adjustment parameter for 6-mercaptopurine.

    Henrik Hasle (Participant)

    5 Jul 2013

    Activity: Other activity types › Other

  24. A comparison of initial treatment response, risk group stratification and toxicity profile in adults, adolescents and children with acute lymphoblastic leukemia.

    Henrik Hasle (Participant)

    28 Jun 2013

    Activity: Other activity types › Other

  25. The molecular heterogeneity of MML rearranged pediatric AML.

    Henrik Hasle (Participant)

    26 Jun 2013

    Activity: Other activity types › Other

  26. American Society of Hematology; ICM - ASH (External organisation)

    Henrik Hasle (Member)

    2013 → …

    Activity: Membership types › Member of committee, council, board

  27. 2012

  28. Early detection of molecular relapse in pediatric AML.

    Henrik Hasle (Lecturer)

    7 Dec 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  29. Early detection of molecular relapse in AML and possible consequences.: Childhood Leukemia Symposium

    Henrik Hasle (Lecturer)

    23 Apr 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  30. International Standards for diagnostics in AML in 2012.: Childhood Leukemia Symposium

    Henrik Hasle (Lecturer)

    23 Apr 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  31. ALL case with a leukemoid reaction/MDS 16 months before ALL.

    Henrik Hasle (Lecturer)

    21 Apr 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  32. Pre-emptive treatment of relapsed in AML with azacitidine.

    Henrik Hasle (Lecturer)

    21 Apr 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  33. NOPHO-AML current status

    Henrik Hasle (Lecturer)

    18 Apr 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  34. Vidaza program in myeloid leukemia.

    Henrik Hasle (Lecturer)

    18 Apr 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  35. AML treatment and complications: 2nd vietnamese course in pediatric oncology.

    Henrik Hasle (Lecturer)

    9 Feb 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  36. Hyperleukocytosis-Tumor lysis syndrome: 2nd Vietnamese course in pediatric oncology.

    Henrik Hasle (Lecturer)

    9 Feb 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  37. European Society of Paediatric Oncology (SIOPE) (External organisation)

    Henrik Hasle (Member)

    2012 → …

    Activity: Membership types › Member of board or management

  38. 2011

  39. Venous and arterial thromboembolism in children and adolescents in Denmark 1994-2006.

    Henrik Hasle (Participant)

    11 Nov 2011

    Activity: Other activity types › Other

  40. The effects of a controlled family nurse directed intervention program for parents hospitalized with children undergoing allogenic haematopoietic stem cell transplantation.

    Henrik Hasle (Participant)

    8 Nov 2011

    Activity: Other activity types › Other

  41. AML hos børn

    Henrik Hasle (Lecturer)

    26 Oct 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  42. SCT in children with AML indications and results.

    Henrik Hasle (Lecturer)

    15 Oct 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  43. Diagnosis and management of children with MDS and JMML.

    Henrik Hasle (Lecturer)

    10 Jun 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  44. NOPHO AML teatment and outcome.

    Henrik Hasle (Lecturer)

    14 Apr 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  45. Advanced MDS in children.: Diagnosis and management.

    Henrik Hasle (Lecturer)

    26 Mar 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  46. JMML

    Henrik Hasle (Lecturer)

    25 Mar 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  47. Refractory cytopenia in children. Diagnosis and management.

    Henrik Hasle (Lecturer)

    24 Mar 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  48. Late effect of cancer at a young age.: Registrybased studies of the health of cancer patients and their offspring.

    Henrik Hasle (Participant)

    4 Mar 2011

    Activity: Other activity types › Other

  49. 2010

  50. AML: New approaches in diagnostics - new targets for therapy.

    Henrik Hasle (Participant)

    5 Oct 2010

    Activity: Other activity types › Other

  51. Annual meeting of the international BFM study

    Henrik Hasle (Invited speaker)

    3 Oct 2010

    Activity: Talk or presentation types › Lecture and oral contribution

  52. Annual meeting of the international BFM study group

    Henrik Hasle (Invited speaker)

    3 Oct 2010

    Activity: Talk or presentation types › Lecture and oral contribution

  53. MRD in AML: Annual meeting of the International BFM study group.

    Henrik Hasle (Participant)

    3 Oct 2010

    Activity: Other activity types › Other

  54. 7th meeting of EBMT

    Henrik Hasle (Invited speaker)

    2 Jun 2010

    Activity: Talk or presentation types › Lecture and oral contribution

  55. Controversies in indications

    Henrik Hasle (Advisor)

    2 Jun 2010

    Activity: Consultancy types › Consultancy

  56. Mumbai Haematology Group Annual Meeting

    Henrik Hasle (Invited speaker)

    7 Mar 2010

    Activity: Talk or presentation types › Lecture and oral contribution

  57. Mumbai Haematology Group Annual Meeting

    Henrik Hasle (Invited speaker)

    7 Mar 2010

    Activity: Talk or presentation types › Lecture and oral contribution

  58. NFCG meeting

    Henrik Hasle (Invited speaker)

    4 Feb 2010

    Activity: Talk or presentation types › Lecture and oral contribution

  59. 2009

  60. U-kursus i hæmatologi/onkologi for pædiatere

    Henrik Hasle (Participant)

    10 Nov 2009 → …

    Activity: Participating in or organising an event types › Participation in or organisation af a conference

  61. Curative therapy of childhood MDS and JMML. ESO - Euroconference on myelodysplastic syndromes.

    Henrik Hasle (Lecturer)

    24 Oct 2009

    Activity: Talk or presentation types › Lecture and oral contribution

  62. Chairman for sessionen Bone marrow failure and childhood MDS.

    Henrik Hasle (Lecturer)

    22 Oct 2009

    Activity: Talk or presentation types › Lecture and oral contribution

  63. Diagnosis and classification of childhood MDS. ESO - Euroconference on myelodysplastic syndromes.

    Henrik Hasle (Lecturer)

    22 Oct 2009

    Activity: Talk or presentation types › Lecture and oral contribution

  64. SCT in high-risk AML. Best of I-BFM-SG. SIOP annual meeting.

    Henrik Hasle (Lecturer)

    9 Oct 2009

    Activity: Talk or presentation types › Lecture and oral contribution

  65. International summer school in pediatrics.

    Henrik Hasle (Organizer)

    29 Jun 2009 → 21 Aug 2009

    Activity: Participating in or organising an event types › Participation in or organisation af a conference

  66. Chairman for sessionen "MDS therapy and cytogenetics" ved "5th International EWOG congress 20090 on pediatric DMD and bone marrow failure syndromes"

    Henrik Hasle (Lecturer)

    22 Apr 2009

    Activity: Talk or presentation types › Lecture and oral contribution

  67. AML in children. Indications for SCT in the Nordic countries. EBMT 35th annual meeting, Göteborg, Marts 30, 2009.

    Henrik Hasle (Lecturer)

    30 Mar 2009

    Activity: Talk or presentation types › Lecture and oral contribution

  68. Samtaler med alvorlig syke barn og deres foreldre.

    Henrik Hasle (Lecturer)

    5 Feb 2009

    Activity: Talk or presentation types › Lecture and oral contribution

  69. Pediatric Blood & Cancer (External organisation)

    Henrik Hasle (Member)

    2009 → …

    Activity: Membership types › Member of board or management

  70. 2008

  71. Dansk Hæmatologisk Selskabs Transplantationsudvalg (External organisation)

    Henrik Hasle (Member)

    1 Jul 2008 → …

    Activity: Membership types › Member of committee, council, board

  72. AML - Fra tidlig død til langtidsoverlevere. En nordisk succeshistorie.

    Henrik Hasle (Lecturer)

    6 Jun 2008

    Activity: Talk or presentation types › Lecture and oral contribution

  73. Formand for NOPHO leukaemia lymphoma working group. (External organisation)

    Henrik Hasle (Member)

    1 Jun 2008 → …

    Activity: Membership types › Member of committee, council, board

  74. NOPHO (External organisation)

    Henrik Hasle (Member)

    14 May 2008 → …

    Activity: Membership types › Member of committee, council, board

  75. Bone Marrow Failure Syndromes

    Henrik Hasle (Lecturer)

    8 Apr 2008

    Activity: Talk or presentation types › Lecture and oral contribution

  76. Myelodysplastic Syndrome

    Henrik Hasle (Lecturer)

    6 Mar 2008

    Activity: Talk or presentation types › Lecture and oral contribution

  77. 2007

  78. DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Mar 2007 → …

    Activity: Membership types › Member of committee, council, board

  79. Formand for speciallægerådet i pædiatri i Region Midt. (External organisation)

    Henrik Hasle (Member)

    1 Jan 2007 → …

    Activity: Membership types › Member of committee, council, board

  80. Specialerådet i pædiatri i Region Midt (External organisation)

    Henrik Hasle (Member)

    1 Jan 2007 → …

    Activity: Membership types › Member of committee, council, board

  81. 2006

  82. Udvalg (External organisation)

    Henrik Hasle (Member)

    1 Aug 2006 → 12 Jan 2007

    Activity: Membership types › Member of review committee

  83. Bestyrelsesmedlem af DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Mar 2006 → …

    Activity: Membership types › Member of committee, council, board

  84. 2004

  85. Dansk leukæmi/lymfom specialgruppe under DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Jan 2004 → …

    Activity: Membership types › Member of committee, council, board

  86. NOPHO-AML 2004 protokollen (External organisation)

    Henrik Hasle (Member)

    1 Jan 2004 → …

    Activity: Membership types › Member of committee, council, board

  87. 2002

  88. Formand for NOPHO AML-gruppen. Principal investigator af NOPHO-AML 2004 protokollen. (External organisation)

    Henrik Hasle (Member)

    1 Feb 2002 → …

    Activity: Membership types › Member of committee, council, board

  89. 2001

  90. Myeloid malignancies in Down syndrome

    Henrik Hasle (Lecturer)

    25 Mar 2001

    Activity: Talk or presentation types › Lecture and oral contribution

  91. 1993

  92. Koordinator for de nordiske lande for den prospektive EWOG-MDS undersøgelse (External organisation)

    Henrik Hasle (Member)

    1 Jun 1993 → …

    Activity: Membership types › Member of committee, council, board